Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy
Clinical trial NCT03333590 · COMPLETED
Trial details
- NCT number
- NCT03333590
- Sponsor
- Kevin Flanigan
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2020-11-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.